Free Trial

Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group logo
$13.78 0.00 (0.00%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$13.78 0.00 (-0.04%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, BLCO, and BTSG

Should you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Bausch + Lomb (BLCO), and BrightSpring Health Services (BTSG).

Pediatrix Medical Group vs. Its Competitors

Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Amedisys has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

In the previous week, Amedisys had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 5 mentions for Amedisys and 2 mentions for Pediatrix Medical Group. Amedisys' average media sentiment score of 0.35 beat Pediatrix Medical Group's score of 0.33 indicating that Amedisys is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amedisys
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Pediatrix Medical Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Amedisys presently has a consensus target price of $100.75, indicating a potential upside of 4.80%. Pediatrix Medical Group has a consensus target price of $16.67, indicating a potential upside of 20.95%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amedisys
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Pediatrix Medical Group
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Amedisys has a net margin of 3.79% compared to Pediatrix Medical Group's net margin of -4.17%. Pediatrix Medical Group's return on equity of 17.43% beat Amedisys' return on equity.

Company Net Margins Return on Equity Return on Assets
Amedisys3.79% 12.52% 7.01%
Pediatrix Medical Group -4.17%17.43%6.35%

94.4% of Amedisys shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 2.1% of Amedisys shares are held by insiders. Comparatively, 0.9% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amedisys$2.35B1.34$43.23M$2.7135.48
Pediatrix Medical Group$2.01B0.59-$99.07M-$1.01-13.64

Summary

Amedisys beats Pediatrix Medical Group on 10 of the 16 factors compared between the two stocks.

Get Pediatrix Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MD vs. The Competition

MetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$1.18B$7.31B$5.56B$20.68B
Dividend YieldN/A2.78%5.22%3.71%
P/E Ratio-13.6427.9427.6928.10
Price / Sales0.5932.30386.4636.76
Price / Cash7.8222.0136.8922.53
Price / Book1.556.698.034.58
Net Income-$99.07M$233.06M$3.18B$985.54M
7 Day Performance-1.88%3.33%2.93%2.79%
1 Month Performance-2.37%1.79%1.72%4.37%
1 Year Performance102.35%37.40%34.39%15.08%

Pediatrix Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MD
Pediatrix Medical Group
1.6439 of 5 stars
$13.78
flat
$16.67
+20.9%
+102.5%$1.18B$2.01B-13.644,305
AMED
Amedisys
2.6984 of 5 stars
$98.39
+0.5%
$100.75
+2.4%
-1.1%$3.23B$2.35B36.3119,000News Coverage
AMN
AMN Healthcare Services
4.3028 of 5 stars
$20.73
-0.7%
$32.08
+54.8%
-54.8%$793.54M$2.98B-4.792,968News Coverage
Analyst Revision
CCRN
Cross Country Healthcare
3.8706 of 5 stars
$13.05
+2.0%
$17.93
+37.4%
-3.4%$427.78M$1.34B-24.628,205News Coverage
LH
Labcorp
4.4625 of 5 stars
$262.39
+0.7%
$276.08
+5.2%
+28.0%$21.96B$13.01B30.3375,500Positive News
Insider Trade
DGX
Quest Diagnostics
4.9385 of 5 stars
$179.52
+1.0%
$185.73
+3.5%
+27.3%$20.04B$9.87B22.7049,000News Coverage
Positive News
DVA
DaVita
4.2855 of 5 stars
$142.40
+0.5%
$164.50
+15.5%
+4.4%$10.75B$12.82B14.1176,000Positive News
CHE
Chemed
4.9685 of 5 stars
$485.18
-13.3%
$645.00
+32.9%
-12.1%$7.10B$2.43B23.6315,695News Coverage
Analyst Downgrade
High Trading Volume
CRVL
CorVel
1.0045 of 5 stars
$102.78
-0.8%
N/A+19.4%$5.29B$895.59M55.965,075
BLCO
Bausch + Lomb
3.1096 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-6.0%$4.61B$4.79B-12.6513,500High Trading Volume
BTSG
BrightSpring Health Services
1.4959 of 5 stars
$23.59
+0.2%
$24.90
+5.6%
+98.5%$4.15B$11.27B84.2535,000Analyst Upgrade

Related Companies and Tools


This page (NYSE:MD) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners